Bioventus reported a 3% increase in Q3 revenue to $142.4 million, driven mainly by growth in Pain Treatments. GAAP earnings per share rose to $0.08 from $0.05, with non-GAAP earnings at $0.17 per share, up 13%. The company generated $20.7 million in operating cash flow and is reviewing strategic alternatives to maximize shareholder value. Bioventus reaffirmed its 2026 guidance, expecting net sales growth of 4-5% and adjusted EPS between $0.75 and $0.79.
Bioventus' third quarter financial results provide context for readers interested in health sector trends. For readers following health stocks, here is Pluang's market snapshot as of Nov 03, 2026 04:11 WIB: out of 150 priced US health-sector stocks tradable on Pluang, 48 rose and 100 fell today. Notable movers include IDEXX Laboratories, Inc. (IDXX) at USD 672.00 with a 1-day change of +21.91% and a typical hold time of 46 days, Illumina, Inc. (ILMN) at USD 236.73 down 18.39%, and American Well Corp (AMWL) at USD 12.71 down 15.15% but with 100% buy order activity.
Zentalis Pharmaceuticals awarded 136,000 non-qualified stock options to four newly hired employees as an inducement to join the company, under Nasdaq Listing Rule 5635(c)(4). The options have an exercise price of $1.85, matching the stock's closing p...
Dianthus Therapeutics, a clinical-stage biotech company, granted stock options to three new non-executive employees as inducements for joining the company. The options cover 26,000 shares at an exercise price of $82.25, vesting over four years. This ...
The Federal Home Loan Bank of Atlanta announced the election of three new member directors and the re-election of one independent director to its board for 2026. Suzanne DeFerie was named Chair and Kathy McKinney Vice Chair for 2027, ensuring experie...
The FDA placed Bright Minds Biosciences' planned Phase 2 epilepsy trial for BMB-101 on partial clinical hold due to toxicity findings in mice and insufficient pharmacokinetic and juvenile-toxicity data. This action caused a sharp decline in the compa...
NVIDIA has published detailed implementation recipes for its Cosmos world models, enabling developers to create simulations for vehicles, robots, and surgical procedures. These recipes guide model adaptation, testing, and GPU deployment, supporting v...
